Pathophysiological, immunological, and inflammatory features of long COVID


Karen Bohmwald1,2†Benjamín Diethelm-Varela1†Linmar Rodríguez-Guilarte1 , et. al., Front. Immunol., 27 February 2024, Sec. Viral Immunology, Volume 15 – 2024 | https://doi.org/10.3389/fimmu.2024.1341600 The COVID-19 pandemic continues to cause severe global disruption, resulting in significant excess mortality, overwhelming healthcare systems, and imposing substantial social and economic burdens on nations. While most of the attention and therapeutic efforts have […]

Breathing difficulties after covid-19: a guide for primary care


BMJ 2023; 381 doi: https://doi.org/10.1136/bmj-2023-074937 , June 2023) Cite this as: BMJ 2023;381:e074937, Rachael Evans, Anton Pick, et. al. What you need to know Around one in four adults who were hospitalised with covid-19 and one in six who were not hospitalised experience persistent breathing difficulties beyond four weeks after SARS-CoV-2 infection,12 and a cohort study in China demonstrated that breathlessness can persist […]

Long COVID Now Looks like a Neurological Disease, Helping Doctors to Focus Treatments


The causes of long COVID, which disables millions, may come together in the brain and nervous system BY STEPHANI SUTHERLAND Scientific American, 2023 Issue Neuroscience Tara Ghormley has always been an overachiever. She finished at the top of her class in high school, graduated summa cum laude from college and earned top honors in veterinary school. […]

Cardiorespiratory dysautonomia in post-COVID-19 condition: Manifestations, mechanisms and management


Artur Fedorowski, Monika Fagevik Olsén, Frida Nikesjö, Christer Janson, Judith Bruchfeld, Maria Lerm, Kristofer Hedma: May 2023, Journal of Internal MedicineVolume 294, Issue 5 p. 548-562 Abstract A significant proportion of COVID-19 patients experience debilitating symptoms for months after the acute infection. According to recent estimates, approximately 1 out of 10 COVID-19 convalescents reports persistent health issues more than 3 months after […]

Dysautonomia and small fiber neuropathy in post-COVID condition and Chronic Fatigue Syndrome


N. Azcue, R. Del Pino, et. al., Journal of Translational Medicine volume 21, Article number: 814 (2023)  Abstract Background Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and post-COVID condition can present similarities such as fatigue, brain fog, autonomic and neuropathic symptoms. Methods The study included 87 patients with post-COVID condition, 50 patients with ME/CFS, and 50 healthy controls (HC). The hemodynamic autonomic function was […]

Study finds 67% of individuals with long COVID are developing dysautonomia


By Shanet usan Alex, News Medical Life Sciences In a recent study posted to the medRxiv* preprint server, researchers analyzed the traits of autonomic symptom burden in long coronavirus disease (COVID). Study: Characterization of Autonomic Symptom Burden in Long COVID: A Global Survey of 2,314 Adults. This news article was a review of a preliminary scientific report that had […]

COVID-19 Long-haul Fatigue Might be Similar to Chronic Fatigue Syndrome and Treated in a Similar Manner


There is no cure or approved treatment for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). However, some symptoms can be treated or managed. Treating these symptoms might provide relief for some patients with ME/CFS but not others. Other strategies, like learning new ways to manage activity, can also be helpful. Patients, their families, and healthcare providers need […]

Orthostatic tachycardia after covid-19


BMJ 2023; 380 doi: https://doi.org/10.1136/bmj-2022-073488 (Published 24 February 2023)Cite this as: BMJ 2023;380:e073488, Ana B Espinosa-Gonzalez, Harsha Master, Nicholas Gall, Natalie Rogers, Trisha Greenhalgh What you need to know Patients with long covid—defined by the National Institute for Health and Care Excellence (NICE) as signs and symptoms that persist for more than four weeks (and especially more than 12 weeks) following acute […]

Conflicting Evidence Of mRNA Technology Raises Serious Concerns About Rush For Use In New Vaccine Development


Authored by Megan Redshaw via The Epoch Times, FRIDAY, SEP 01, 2023 The U.S. government and pharmaceutical companies are investing a substantial amount to develop new mRNA vaccines for infectious diseases and cancer, fueling a lucrative mRNA platform valued at $136.2 billion. A newly established White House program announced on Aug. 23 that it is granting a […]

Long COVID Now Looks like a Neurological Disease, Helping Doctors to Focus Treatments


The causes of long COVID, which disables millions, may come together in the brain and nervous system Stephani Sutherland on March 1, 2023 Tara Ghormley has always been an overachiever. She finished at the top of her class in high school, graduated summa cum laude from college and earned top honors in veterinary school. She went on […]